Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Academic Licensing Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: GNT003
MIFTS: 57

Genital Herpes

Categories: Infectious diseases, Reproductive diseases
Genes Tissues Related diseases Publications Pathways Symptoms & Phenotypes Drugs
Sources

Aliases & Classifications for Genital Herpes

About this section

MalaCards integrated aliases for Genital Herpes:

Name: Genital Herpes 12 55 43 3 15 73
Herpes Genitalis 12 44
Genital Herpes Simplex 12
Virus-Genital Herpes 12
Herpes Genitalia 12
Venereal Herpes 12

Classifications:

MalaCards categories:
Global: Infectious diseases
Anatomical: Reproductive diseases
See all MalaCards categories (disease lists)


External Ids:

Disease Ontology 12 DOID:8704
ICD9CM 35 054.1 054.10
MeSH 44 D006558
NCIt 50 C14364
UMLS 73 C0019342
Sources

Summaries for Genital Herpes

About this section
MedlinePlus : 43 Genital herpes is a sexually transmitted disease (STD) caused by a herpes simplex virus (HSV). It can cause sores on your genital or rectal area, buttocks, and thighs. You can get it from having vaginal, anal, or oral sex with someone who has it. The virus can spread even when sores are not present. Mothers can also infect their babies during childbirth. Symptoms of herpes are called outbreaks. You usually get sores near the area where the virus has entered the body. The sores are blisters which break and become painful, and then heal. Sometimes people do not know they have herpes because they have no symptoms or very mild symptoms. The virus can be more serious in newborn babies or in people with weak immune systems. Repeat outbreaks are common, especially during the first year. Over time, you get them less often and the symptoms become milder. The virus stays in your body for life. There are tests that can diagnose genital herpes. There is no cure. However, medicines can help lessen symptoms, decrease outbreaks, and lower the risk of passing the virus to others. Correct usage of latex condoms can reduce, but not eliminate, the risk of catching or spreading herpes. The most reliable way to avoid infection is to not have anal, vaginal, or oral sex.

MalaCards based summary : Genital Herpes, also known as herpes genitalis, is related to cytomegalovirus infection and meningitis, and has symptoms including sores, fever and swollen gl. An important gene associated with Genital Herpes is ACKR1 (Atypical Chemokine Receptor 1 (Duffy Blood Group)), and among its related pathways/superpathways are Akt Signaling and Toll-like Receptor Signaling Pathway. The drugs Acyclovir and Famciclovir have been mentioned in the context of this disorder. Affiliated tissues include genital system, rectum and testes, and related phenotypes are digestive/alimentary and hematopoietic system

Disease Ontology : 12 A herpes simplex that results in infection located in genital system, or located in rectum, has material basis in Human herpesvirus 1 or has material basis in Human herpesvirus 2, which is transmitted by sexual contact. The infection has symptom sores, has symptom fever, and has symptom swollen glands.

Wikipedia : 76 Genital herpes is an infection by herpes simplex virus (HSV) of the genitals. Most people either have no... more...

Sources

Related Diseases for Genital Herpes

About this section

Diseases related to Genital Herpes via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 148)
# Related Disease Score Top Affiliating Genes
1 cytomegalovirus infection 29.6 CCL5 IL10
2 meningitis 28.9 IL10 TLR2 TLR9
3 herpes simplex 11.7
4 herpes simplex encephalitis 11.3
5 tropical endomyocardial fibrosis 10.8 IL10 IL4
6 hyperlucent lung 10.7 IL10 IL4
7 tungiasis 10.7 IL10 IL4
8 endomyocardial fibrosis 10.7 IL10 IL4
9 immunoglobulin a deficiency 1 10.7 IL10 IL4
10 retinitis pigmentosa 22 10.7 IL10 IL4
11 baylisascariasis 10.7 IL10 IL4
12 gastrointestinal allergy 10.7 CCL5 IL4
13 chronic conjunctivitis 10.7 CCL5 IL4
14 apple allergy 10.7 IL10 IL4
15 beta-lactam allergy 10.7 IL10 IL4
16 vulvovaginitis 10.7 CCL5 IL10
17 kimura disease 10.7 CCL5 IL4
18 folliculitis 10.6 CCL5 IL4
19 vernal keratoconjunctivitis 10.6 CCL5 IL4
20 buruli ulcer 10.6 IL10 IL4
21 poliomyelitis 10.6 IL10 IL4
22 latex allergy 10.5 IL18 IL4
23 bardet-biedl syndrome 15 10.5 IL10 IL4
24 eosinophilic gastritis 10.5 IL18 IL4
25 griscelli syndrome, type 2 10.5 CCL5 IL10
26 necrotizing ulcerative gingivitis 10.5 IL10 IL18
27 eales disease 10.5 IL10 IL4
28 cow milk allergy 10.5 IL10 IL18
29 radiculopathy 10.5 CCL5 IL10
30 stachybotrys chartarum 10.4 CCL5 IL18
31 orofacial granulomatosis 10.4 CCL5 IL10 IL4
32 eye lymphoma 10.4 IL10 TLR9
33 mycetoma 10.4 CCL5 IL10
34 allergic asthma 10.4 CCL5 IL10 IL4
35 interstitial lung disease 10.4 CCL5 IL10 IL4
36 mucocutaneous leishmaniasis 10.4 IL10 TLR9
37 spotted fever 10.3 CCL5 IL10
38 traumatic brain injury 10.3 APOE IL10
39 acute graft versus host disease 10.3 IL10 IL18 IL4
40 coccidiosis 10.2 IL10 IL4 TLR9
41 extrinsic cardiomyopathy 10.2 IL10 IL4 TLR9
42 keratoconjunctivitis sicca 10.2 IL10 IL4 TLR9
43 allergic rhinitis 10.2 IL10 IL18 IL4
44 nasal cavity disease 10.2 IL10 IL4 TLR9
45 opportunistic mycosis 10.2 IL10 IL4 TLR9
46 rhinitis 10.2 CCL5 IL4 TLR9
47 nose disease 10.2 IL10 IL4 TLR9
48 parasitic helminthiasis infectious disease 10.2 IL10 IL4 TLR9
49 upper respiratory tract disease 10.2 IL10 IL4 TLR9
50 toxoplasmosis 10.1 IL10 IL4 TLR9

Comorbidity relations with Genital Herpes via Phenotypic Disease Network (PDN):


Acute Cystitis

Graphical network of the top 20 diseases related to Genital Herpes:



Diseases related to Genital Herpes
Sources

Symptoms & Phenotypes for Genital Herpes

About this section

Symptoms:

12
  • • sores
  • • fever
  • • swollen gl

UMLS symptoms related to Genital Herpes:


fever, pelvic pain, pruritus

MGI Mouse Phenotypes related to Genital Herpes:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 digestive/alimentary MP:0005381 9.92 IL4 TBX21 TBXT APOE TLR2 TLR9
2 hematopoietic system MP:0005397 9.86 IL18 IL4 TBX21 APOE TLR2 CCL5
3 homeostasis/metabolism MP:0005376 9.81 IL18 IL4 TBX21 TBXT ACKR1 APOE
4 immune system MP:0005387 9.61 IL4 TBX21 ACKR1 APOE TLR2 CCL5
5 integument MP:0010771 9.1 IL18 IL4 TBXT APOE TLR2 IL10
Sources

Drugs & Therapeutics for Genital Herpes

About this section

Drugs for Genital Herpes (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 26)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Acyclovir Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 59277-89-3 2022
2
Famciclovir Approved, Investigational Phase 4,Phase 3 104227-87-4 3324
3 valacyclovir Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
4 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
5 Antiviral Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
6
Tenofovir Phase 4 147127-20-6 464205
7 2-Aminopurine Phase 4,Phase 3
8 Reverse Transcriptase Inhibitors Phase 4
9 Nucleic Acid Synthesis Inhibitors Phase 4
10 Anti-HIV Agents Phase 4
11 Anti-Retroviral Agents Phase 4
12 Antimetabolites Phase 4,Phase 3
13
Halofantrine Approved Phase 3 69756-53-2 37393
14
Aluminum sulfate Approved Phase 3 10043-01-3
15 Monophosphoryl lipid A Phase 3
16 interferons Phase 3
17 Adjuvants, Immunologic Phase 3,Phase 2
18 Vaccines Phase 3,Phase 2,Phase 1
19 Anti-Bacterial Agents Phase 3
20 Antibiotics, Antitubercular Phase 3
21 Interferon Inducers Phase 3
22 Krestin Phase 3,Phase 2
23 Protective Agents Phase 3
24 Radiation-Protective Agents Phase 3
25
QS 21 Phase 2 141256-04-4
26 Lecithin Nutraceutical Phase 2

Interventional clinical trials:

(show top 50) (show all 75)
# Name Status NCT ID Phase Drugs
1 Patient-initiated Episodic Treatment of Recurrent Genital Herpes in Black Patients Completed NCT00477334 Phase 4 Famciclovir;Placebo
2 A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of Herpes Simplex Virus HSV-2 Genital Herpes In Newly Diagnosed Patients. VALTREX® Tablet is a Trademark of the GlaxoSmithKline Group of Companies. Completed NCT00158860 Phase 4 valaciclovir (VALTREX®)
3 RELIEF: Randomized Episodic Versus Long-Term Suppression Experience With Famciclovir Completed NCT00219310 Phase 4 Famciclovir
4 A Study to Evaluate the Effect of Famciclovir in Reducing Herpes Virus Shedding Completed NCT00129818 Phase 4 Famciclovir
5 Trial to Study the Effect of Dose of Herpes Simplex Virus-2 (HSV-2) Suppressive Therapy on HSV and HIV Completed NCT00527618 Phase 4 valacyclovir;acyclovir
6 Effect of Tenofovir on Genital Herpes Simplex Virus (HSV) Shedding Completed NCT01448616 Phase 4 TDF;Placebo Vaginal Gel;Vaginal TFV Gel;Placebo Tablets
7 Randomized Trial to Evaluate Suppressive Effect of High-Dose Valacyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2 Completed NCT01346475 Phase 4 valacyclovir;Valacyclovir
8 Randomized Trial to Evaluate Suppressive Effect of High-Dose Acyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2 Completed NCT00362297 Phase 4 acyclovir;valacyclovir
9 VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2 Completed NCT00306293 Phase 4 valacyclovir
10 A Randomized Trial to Evaluated the Suppressive Effect of Acyclovir on Rapidly Cleared HSV-2 Reactivation Completed NCT00723229 Phase 4 acyclovir
11 VALTREX Once Daily For Viral Shedding In Herpes Simplex Virus 2 (HSV-2) Seropositive Subjects. VALTREX® Tablet is a Trademark of GlaxoSmithKline Group of Companies. Completed NCT00116844 Phase 4 Valaciclovir;Placebo
12 Effect of HSV-2 Suppressive Therapy on Sexual Behavior Active, not recruiting NCT00495716 Phase 4 acyclovir;acyclovir
13 A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection In HIV-Infected Persons Terminated NCT00079911 Phase 4 valacyclovir hydrochloride
14 A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected Patients Unknown status NCT00005663 Phase 3 Valacyclovir hydrochloride
15 Trial of Male Circumcision: HIV, Sexually Transmitted Disease (STD) and Behavioral Effects in Men, Women and the Community Unknown status NCT00124878 Phase 3
16 Efficacy and Safety of Famciclovir 1-day Treatment Compared to 3-day Treatment With Valacyclovir in Adults With Recurrent Genital Herpes Completed NCT00306787 Phase 3 Famciclovir;Valacyclovir;Placebo matching famciclovir;Placebo matching valacyclovir
17 Efficacy and Safety of Oral Famciclovir in Patients With Active Recurrent Genital Herpes Completed NCT00171990 Phase 3 Famciclovir
18 Efficacy of Oral Famciclovir 125mg Comparing to Aciclovir 200 mg Treatment in Patients With Active Recurrent Genital Herpes Completed NCT01281007 Phase 3 Famciclovir;Aciclovir
19 Safety of a Herpes Simplex Candidate Vaccine (gD2t) With MPL and Its Efficacy to Prevent Genital Herpes Disease Completed NCT00699764 Phase 3
20 HerpeVac Trial for Young Women Completed NCT00057330 Phase 3
21 A Study of Acyclovir to Help Prevent HIV Infection in People With Genital Herpes Completed NCT00076232 Phase 3 Acyclovir;Acyclovir placebo
22 Safety Evaluation of Herpes Simplex Candidate Vaccine (gD2t) With Adjuvant in HSV Seropositive / Seronegative Subjects Completed NCT00698568 Phase 3
23 Herpes Simplex Virus Type 2 (HSV-2) Suppression to Prevent HIV Transmission Completed NCT00194519 Phase 3 Generic acyclovir;Placebo
24 Open-label Study of ASP2151 in Herpes Simplex Patients Completed NCT02209324 Phase 3 ASP2151
25 Valaciclovir to Prevent Transmission of Herpes Simplex Virus Completed NCT00001649 Phase 3 Valaciclovir
26 Trial to Evaluate PRO 2000/5 Gels for the Prevention of Vaginally Acquired HIV Infection Completed NCT00262106 Phase 3 PRO 2000/5;Placebo
27 Valaciclovir Hydrochloride Phase III for Hematopoietic Stem Cell Transplantation Patients Completed NCT01602562 Phase 3 VACV tablets (Adults or pediatrics) or granules (pediatrics)
28 Can Valacyclovir Delay the Need for Initiation of Human Immunodeficiency Virus (HIV) Treatment in HIV-infected Individuals? Completed NCT00860977 Phase 3 valacyclovir;Placebo
29 Effect of Male Circumcision on HIV Incidence (ANRS 1265) Terminated NCT00122525 Phase 3
30 A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes Completed NCT00486200 Phase 2 ASP2151;valacyclovir;Placebo
31 Biological Efficacy Study of HerpV Vaccine With QS-21 to Treat Subjects With Recurrent Genital Herpes Completed NCT01687595 Phase 2 HerpV and QS-21;Placebo
32 Randomised Controlled Trial Assessing the Impact of Genital Herpes Suppressive Therapy on HIV Shedding Completed NCT00158509 Phase 2 Valacyclovir
33 Evaluating New Formulation of Therapeutic HSV-2 Vaccine Completed NCT02515175 Phase 2 Placebo
34 Safety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in Adults Completed NCT02030301 Phase 1, Phase 2
35 Safety and Efficacy Study for a New Antiviral Drug to Treat Genital Herpes Type 2 Completed NCT01047540 Phase 2 AIC316;AIC316;AIC316;AIC316;Placebo
36 Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine Completed NCT02114060 Phase 2
37 Rollover Trial for Placebo Subjects Previously Enrolled Into GEN-003-002 Study Completed NCT02300142 Phase 2
38 Safety and Immunogenicity Study of Therapeutic HSV-2 Vaccine Completed NCT01667341 Phase 1, Phase 2
39 Retention and Duration of Activity of SPL7013 (VivaGel®) After Vaginal Dosing. Completed NCT00740584 Phase 1, Phase 2 3% SPL7013 Gel (VivaGel)
40 Anti-Herpetic Treatment of Genital Ulcer : Effect on HIV & Herpes Shedding (ANRS 1212) Completed NCT00158483 Phase 2 Acyclovir (ACV)
41 Acyclovir to Treat Patients Co-infected With HIV and Herpes Viruses in Uganda Completed NCT00405821 Phase 2 Acyclovir;Placebo
42 Maintenance Dose Study of GEN-003 in Subjects With Genital Herpes Infection Active, not recruiting NCT03146403 Phase 2
43 Safety and Efficacy Study of Herpes Simplex Virus Type 2 (HSV-2) Therapeutic DNA Vaccine Active, not recruiting NCT02837575 Phase 2
44 A Study to Investigate the Efficacy, Safety and Tolerability of PEG in Patients With Genital Herpes Terminated NCT01765114 Phase 2 PEG-Formulation
45 Safety and Efficacy Comparator Trial of a New Drug Against Genital Herpes Terminated NCT01658826 Phase 2 AIC316;Valacyclovir
46 Safety Study of HSV2 DNA Vaccine to Treat Patients With Recurrent Genital Herpes Caused by HSV-2 Completed NCT00274300 Phase 1
47 Trial Evaluating Safety, Tolerability and Immune Response of AG-707 Completed NCT00231049 Phase 1 AG-707
48 Study of the Safety of a Particular Herpes Vaccine in Adults With or Without Herpes Infection Completed NCT01915212 Phase 1
49 Study to Evaluate the Safety and Pharmacokinetics of Single Doses of ASP2151 in Healthy Male Subjects and the Effects of Food Completed NCT02852876 Phase 1 ASP2151;Placebo
50 Evaluating Three Grams Daily Valacyclovir in Patients With Chronic Hepatitis C and HSV-2 Infection (Phase I) Completed NCT01453075 Phase 1 Valacyclovir;Placebo

Search NIH Clinical Center for Genital Herpes

Inferred drug relations via UMLS 73 / NDF-RT 51 :


Cochrane evidence based reviews: herpes genitalis

Sources

Genetic Tests for Genital Herpes

About this section
Sources

Anatomical Context for Genital Herpes

About this section

The Foundational Model of Anatomy Ontology organs/tissues related to Genital Herpes:

19
Genital System, Rectum

MalaCards organs/tissues related to Genital Herpes:

41
Testes, T Cells, Cervix, Skin, B Cells, Nk Cells, Myeloid
Sources

Publications for Genital Herpes

About this section

Articles related to Genital Herpes:

(show top 50) (show all 604)
# Title Authors Year
1
CXCL17 Chemokine-Dependent Mobilization of CXCR8<sup>+</sup>CD8<sup>+</sup> Effector Memory and Tissue-Resident Memory T Cells in the Vaginal Mucosa Is Associated with Protection against Genital Herpes. ( 29549178 )
2018
2
Interferon epsilon in the reproductive tract of healthy and genital herpes simplex virus-infected pregnant women: Results of a pilot study. ( 29905034 )
2018
3
Genome-Wide Surveillance of Genital Herpes Simplex Virus Type 1 From Multiple Anatomic Sites Over Time. ( 29920588 )
2018
4
STING agonists enable antiviral cross-talk between human cells and confer protection against genital herpes in mice. ( 29608601 )
2018
5
Prevention and management of genital herpes simplex infection during pregnancy and delivery: Guidelines from the French College of Gynaecologists and Obstetricians (CNGOF). ( 29571124 )
2018
6
Health-related quality of life of young people and adults with primary or recurrent episodes of genital herpes: a mixed methods systematic review protocol. ( 29762300 )
2018
7
Genital herpes stigma: Toward the Measurement and Validation of a highly prevalent yet hidden public health problem. ( 29629409 )
2018
8
A model of genital herpes simplex virus Type 1 infection in Rhesus Macaques. ( 28748667 )
2017
9
Dual-strain genital herpes simplex virus type 2 (HSV-2) infection in the US, Peru, and 8 countries in sub-Saharan Africa: A nested cross-sectional viral genotyping study. ( 29281620 )
2017
10
A case of MOG antibody-positive bilateral optic neuritis and meningoganglionitis following a genital herpes simplex virus infection. ( 29055448 )
2017
11
Serologic Screening for Genital Herpes Infection: Recommendation Statement. ( 28671418 )
2017
12
First-episode genital herpes: interventions for men and women. ( 28120659 )
2017
13
Potential risk of developing herpes simplex encephalitis in patients treated with sildenafil following primary exposure to genital herpes. ( 28956417 )
2017
14
Therapeutic Vaccine for Genital Herpes Simplex Virus-2 Infection: Findings From a Randomized Trial. ( 28329211 )
2017
15
Leflunomide in the Treatment of a Pseudotumoral Genital Herpes Simplex Virus Infection in an HIV Patient. ( 28373917 )
2017
16
Dorsal longitudinal foreskin cut is associated with reduced risk of HIV, syphilis and genital herpes in men: a cross-sectional study in Papua New Guinea. ( 28406272 )
2017
17
Genital herpes. ( 28619732 )
2017
18
2017 European guidelines for the management of genital herpes. ( 28836892 )
2017
19
Primary syphilis in pregnancy mistaken for genital herpes: A preventable cause of congenital syphilis. ( 29103618 )
2017
20
Cutting Edge: Genetic Association between IFI16 Single Nucleotide Polymorphisms and Resistance to Genital Herpes Correlates with IFI16 Expression Levels and HSV-2-Induced IFN-I^ Expression. ( 28893956 )
2017
21
Serologic Screening for Genital Herpes Infection. ( 28671417 )
2017
22
Comparison of Acyclovir and Multistrain Lactobacillus brevis in Women with Recurrent Genital Herpes Infections: a Double-Blind, Randomized, Controlled Study. ( 28852985 )
2017
23
Extensive and refractory genital herpes in human immunodeficiency virus-infected patient successfully treated with imiquimod: Case report and literature review. ( 28164895 )
2017
24
A Comparative Analysis of Polymerase Chain Reaction and Direct Fluorescent Antibody Test for Diagnosis of Genital Herpes. ( 28042218 )
2017
25
Prospective cohort study showing persistent HSV-2 shedding in women with genital herpes 2 years after acquisition. ( 29175899 )
2017
26
A trivalent subunit antigen glycoprotein vaccine as immunotherapy for genital herpes in the guinea pig genital infection model. ( 28481687 )
2017
27
Genital Herpes Infection in an Adolescent with Diabetes Mellitus. ( 28891491 )
2017
28
Genital herpes. ( 27109044 )
2016
29
Medroxyprogesterone acetate and levonorgestrel increase genital mucosal permeability and enhance susceptibility to genital herpes simplex virus type 2 infection. ( 27007679 )
2016
30
Collaboration with a midwife in the care of a pregnant patient with recurrent genital herpes simplex virus. ( 27412208 )
2016
31
Serologic Screening for Genital Herpes: An Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. ( 27997660 )
2016
32
Genital Herpes. ( 27959657 )
2016
33
Clinical study in genital herpes: natural Gene-Eden-VIR/Novirin versus acyclovir, valacyclovir, and famciclovir. ( 27621592 )
2016
34
Role of type-specific herpes simplex virus-1 and 2 serology as a diagnostic modality in patients with clinically suspected genital herpes: A comparative study in Indian population from a tertiary care hospital. ( 27510668 )
2016
35
Genital Herpes: What You Should Know. ( 27281843 )
2016
36
Attitudes and Willingness to Assume Risk of Experimental Therapy to Eradicate Genital Herpes Simplex Virus Infection. ( 27513383 )
2016
37
Current Concepts for Genital Herpes Simplex Virus Infection: Diagnostics and Pathogenesis of Genital Tract Shedding. ( 26561565 )
2016
38
JAMA patient page: Screening for Genital Herpes. ( 27997655 )
2016
39
Integrative pharmacokinetic-pharmacodynamic modeling and simulation of amenamevir (ASP2151) for treatment of recurrent genital herpes. ( 27461507 )
2016
40
A Recommendation Against Serologic Screening for Genital Herpes Infection-What Now? ( 27997636 )
2016
41
Herpes simplex virus: 'to disclose or not to disclose.' An exploration of the multi-disciplinary team's role in advising patients about disclosure when diagnosed with genital herpes simplex virus. ( 27582307 )
2016
42
Genital Herpes: A Review. ( 27281837 )
2016
43
Protection from genital herpes disease, seroconversion and latent infection in a non-lethal murine genital infection model by immunization with an HSV-2 replication-defective mutant virus. ( 26609935 )
2016
44
CLINICAL PRACTICE. Genital Herpes. ( 27532832 )
2016
45
Serologic Screening for Genital Herpes Infection: US Preventive Services Task Force Recommendation Statement. ( 27997659 )
2016
46
The occurrence of herpes simplex viruses 1 and 2 in skin and mucosal lesions in patients with suspicion of genital herpes. ( 28146623 )
2016
47
Intravaginal Zinc Oxide Tetrapod Nanoparticles as Novel Immunoprotective Agents against Genital Herpes. ( 27183601 )
2016
48
Unfortunate synergy between HIV and genital herpes. ( 26884529 )
2016
49
Optimal management of genital herpes: current perspectives. ( 27358569 )
2016
50
Genital Herpes. ( 27959656 )
2016
Sources

Variations for Genital Herpes

About this section
Sources

Expression for Genital Herpes

About this section
Search GEO for disease gene expression data for Genital Herpes.
Sources

Pathways for Genital Herpes

About this section

Pathways related to Genital Herpes according to GeneCards Suite gene sharing:

(show all 22)
# Super pathways Score Top Affiliating Genes
1
Akt Signaling 64
Show member pathways
 13.17 CCL5 IL10 IL18 IL4 TLR2 TLR9
2
Toll-like Receptor Signaling Pathway 37 1
Show member pathways
 12.76 CCL5 IL10 IL18 TLR2 TLR9
3
Influenza A 37
Show member pathways
 12.56 CCL5 IL18 IL4 TLR2 TLR9
4
Th17 cell differentiation 37
Show member pathways
 12.19 IL10 IL18 IL4 TBX21 TLR2
5
Toxoplasmosis 37
Show member pathways
 12.05 IL10 IL4 TLR2
6
Tuberculosis 37
12.01 IL10 IL18 TLR2 TLR9
7
Bacterial infections in CF airways 22
Show member pathways
 11.96 IL4 TLR2 TLR9
8
NF-kappaB Signaling 4
11.95 CCL5 IL10 IL4 TBX21 TLR2 TLR9
9
Th1 Differentiation Pathway 65
Show member pathways
 11.93 IL10 IL18 TBX21 TLR2 TLR9
10
Immune response IFN gamma signaling pathway 22
Show member pathways
 11.87 CCL5 IL10 IL18 IL4
11
Interleukin-4 and 13 signaling 66
11.77 IL10 IL18 IL4
12
IL12-mediated signaling events 1
Show member pathways
 11.75 IL18 IL4 TBX21
13
Rheumatoid arthritis 37
11.63 CCL5 IL18 TLR2
14
Innate Lymphoid Cell Differentiation Pathways 65
11.53 IL10 IL18 IL4 TBX21
15
African trypanosomiasis 37
11.15 IL10 IL18 TLR9
16
Interleukin-10 signaling 66
11.15 CCL5 IL10 IL18 IL4
17
Development and heterogeneity of the ILC family 1
11.09 IL18 IL4 TBX21
18
Cytokines and Inflammatory Response 1
11.08 IL10 IL4
19
IL12 signaling mediated by STAT4 1
11.04 IL18 TBX21
20
OX40 Pathway 64
11 IL10 IL4
21
IL1 and megakaryocytes in obesity 1
10.97 IL18 TLR2
22
Malaria 37
10.71 ACKR1 IL10 IL18 TLR2 TLR9
Sources

GO Terms for Genital Herpes

About this section

Cellular components related to Genital Herpes according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.7 APOE CCL5 IL10 IL18 IL4 PI3
2 extracellular space GO:0005615 9.17 APOE CCL5 IFNL4 IL10 IL18 IL4
3 amyloid-beta complex GO:0106003 8.96 APOE TLR2

Biological processes related to Genital Herpes according to GeneCards Suite gene sharing:

(show all 31)
# Name GO ID Score Top Affiliating Genes
1 immune response GO:0006955 9.89 CCL5 IL10 IL18 IL4 TLR2
2 cytokine-mediated signaling pathway GO:0019221 9.87 CCL5 IL10 IL18 IL4
3 positive regulation of inflammatory response GO:0050729 9.72 IL18 TLR2 TLR9
4 regulation of signaling receptor activity GO:0010469 9.72 CCL5 IFNL4 IL10 IL18 IL4
5 MyD88-dependent toll-like receptor signaling pathway GO:0002755 9.65 TLR2 TLR9
6 positive regulation of interleukin-8 production GO:0032757 9.65 TLR2 TLR9
7 triglyceride homeostasis GO:0070328 9.64 APOE IL18
8 negative regulation of interleukin-6 production GO:0032715 9.64 IL10 TLR9
9 positive regulation of interferon-beta production GO:0032728 9.63 TLR2 TLR9
10 positive regulation of interleukin-12 production GO:0032735 9.63 TLR2 TLR9
11 positive regulation of interleukin-10 production GO:0032733 9.62 TLR2 TLR9
12 positive regulation of chemokine production GO:0032722 9.62 TLR2 TLR9
13 positive regulation of nitric-oxide synthase biosynthetic process GO:0051770 9.61 TLR2 TLR9
14 I-kappaB phosphorylation GO:0007252 9.61 TLR2 TLR9
15 regulation of cytokine secretion GO:0050707 9.6 TLR2 TLR9
16 neutrophil activation GO:0042119 9.59 CCL5 IL18
17 regulation of T cell activation GO:0050863 9.58 CCL5 IFNL4
18 positive regulation of granulocyte macrophage colony-stimulating factor production GO:0032725 9.58 IL18 TLR9
19 positive regulation of isotype switching to IgG isotypes GO:0048304 9.56 IL4 TBX21
20 positive regulation of MHC class II biosynthetic process GO:0045348 9.54 IL10 IL4
21 positive regulation of NIK/NF-kappaB signaling GO:1901224 9.54 IL18 TLR2 TLR9
22 negative regulation of interleukin-8 production GO:0032717 9.51 IL10 TLR9
23 positive regulation of toll-like receptor signaling pathway GO:0034123 9.48 TLR2 TLR9
24 tumor necrosis factor production GO:0032640 9.46 TLR2 TLR9
25 regulation of isotype switching GO:0045191 9.43 IL10 IL4
26 lipopolysaccharide-mediated signaling pathway GO:0031663 9.43 CCL5 IL18 TLR2
27 inflammatory response GO:0006954 9.43 ACKR1 CCL5 IL10 IL18 TLR2 TLR9
28 positive regulation of interleukin-18 production GO:0032741 9.4 TLR2 TLR9
29 response to molecule of bacterial origin GO:0002237 9.33 IL10 TLR2 TLR9
30 type 2 immune response GO:0042092 8.8 IL10 IL18 IL4
31 positive regulation of transcription by RNA polymerase II GO:0045944 10 IL10 IL18 IL4 TBXT TLR2 TLR9

Molecular functions related to Genital Herpes according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytokine activity GO:0005125 9.02 CCL5 IFNL4 IL10 IL18 IL4
Sources

Sources for Genital Herpes

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....